Search

13 results for “therapeutic drug monitoring”

• Research LetterOpen Access

  Therapeutic drug monitoring of modified release once daily tacrolimus in de novo renal transplant with conversion to a twice daily generic in the stable period

  Bellusci CP, Rocco C, Aulicino P, Mecikovsky D, Curras V

  Vol. 6 · Issue 3 · pp. 154–156

  https://doi.org/10.4103/0976-500X.162021
  Full text ↗PDF

• Review ArticleOpen Access

  L-asparaginase in the treatment of patients with acute lymphoblastic leukemia

  Rachel A. Egler, Sanjay P. Ahuja, Yousif Matloub

  Vol. 7 · Issue 2 · pp. 62–71

  https://doi.org/10.4103/0976-500X.184769
  Full text ↗PDF

• Research PaperOpen Access

  Comparative Effect of Divided Doses of Adult Solid and Liquid Oral Formulations of Antiepileptic Drugs in the Management of Pediatric Epilepsy

  Ravi Prasad Nidanapu, Bascarane Tamijarassy, Subramanian Mahadevan, Batmanabane Gitanjali

  Vol. 8 · Issue 2 · pp. 54–61

  https://doi.org/10.4103/jpp.JPP_7_17
  Full text ↗PDF

• Research ArticleOpen Access

  Exposure to Azathioprine Metabolites and Clinical Outcome in Indian Patients with Crohn’s Disease

  Ratna Prabha, Sumith K. Mathew, A. J. Joseph, Binu Susan Mathew

  Vol. 13 · Issue 3 · pp. 266–271

  https://doi.org/10.1177/0976500X221085804
  Full text ↗PDF

• CorrespondenceOpen Access

  Belatacept: Good, but not good enough?

  Sreejith Parameswaran, R. P. Swaminathan

  Vol. 3 · Issue 1 · pp. 82–83

  https://doi.org/10.4103/0976-500X.92510
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• Case ReportOpen Access

  A case of figurate urticaria by etanercept

  Maurizio Sessa, Maria Giuseppa Sullo, Annamaria Mascolo, Daniela Cimmaruta, Francesca Romano, Rosa Valentina Puca, Annalisa Capuano, Francesco Rossi, Ada Lo Schiavo

  Vol. 7 · Issue 2 · pp. 106–108

  https://doi.org/10.4103/0976-500X.184777
  Full text ↗PDF

• CommentaryOpen Access

  The new factor Xa inhibitor: Apixaban

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 5 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.124409
  Full text ↗PDF

• Molecules of MillenniumOpen Access

  Fospropofol

  Bharti Mahajan, Sandeep Kaushal, Rajesh Mahajan

  Vol. 3 · Issue 3 · pp. 293–294

  https://doi.org/10.4103/0976-500X.99457
  Full text ↗PDF

• Research LetterOpen Access

  Levocetirizine-induced Psychiatric Disorders in a Pediatric Patient: A Case Report and a Pharmacovigilance Database Analysis

  Carla Carnovale, Simone Russo, Gigliola Biondelli, Marta Gentili, Marco Pozzi, Stefania Antoniazzi, Sonia Radice, Emilio Clementi

  Vol. 8 · Issue 2 · pp. 74–6

  https://doi.org/10.4103/jpp.JPP_14_17
  Full text ↗PDF

• EditorialOpen Access

  Are we moving towards a new definition of essential medicines?

  Manikandan S

  Vol. 6 · Issue 3 · pp. 123–5

  https://doi.org/10.4103/0976-500X.162008
  Full text ↗PDF

• Original Research ArticleOpen Access

  Development and Validation of a Robust LC-MS/MS Method for Quantitation of a Novel Kinase Inhibitor, Ritlecitinib, in Rat Plasma: Application in Pharmacokinetic Study

  Katari Pavan Kumar, Areti Anka Rao

  Vol. 16 · Issue 3 · pp. 302–310

  https://doi.org/10.1177/0976500X241289642
  Full text ↗PDF

• Research LetterOpen Access

  Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19 Cardiac Conditions?

  Shridhar Dwivedi, Vinod Sharma, C. R. Patil

  Vol. 13 · Issue 1 · pp. 95–96

  https://doi.org/10.1177/0976500X221080202
  Full text ↗PDF